Skip to Content

Obiltoxaximab SFL

Licence status
Withdrawn: 02/08/2024
Active substances
Obiltoxaximab
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/20/1485/001
Licence holder
SFL Regulatory Services GmbH

Licence information

ATC code
J06BB22 obiltoxaximab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
18/11/2020